-
1
-
-
0029558065
-
A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables
-
NABER D. A self-rating to measure subjective effects of neuroleptic drug relationships to objective psychopathology, quality of life, compliance, and other clinical variables. Int Clin Psychopharmacol 1995;10(Suppl. 3):133-138.
-
(1995)
Int Clin Psychopharmacol
, vol.10
, Issue.SUPPL. 3
, pp. 133-138
-
-
Naber, D.1
-
2
-
-
0029946130
-
Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome
-
AWAD AG, VORUGANTI LN, HESLEGRAVE RJ, HOGAN TP. Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome. Int Clin Psychopharmacol 1996;11(Suppl. 2):55-59.
-
(1996)
Int Clin Psychopharmacol
, vol.11
, Issue.SUPPL. 2
, pp. 55-59
-
-
Awad, A.G.1
Voruganti, L.N.2
Heslegrave, R.J.3
Hogan, T.P.4
-
3
-
-
0036307453
-
Relapse and rehospitalisation rates in patients with schizophrenia: Effects of second generation antipsychotics
-
CSERNANSKY JG, SCHUCHART EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. CNS Drugs 2002;16:473-484.
-
(2002)
CNS Drugs
, vol.16
, pp. 473-484
-
-
Csernansky, J.G.1
Schuchart, E.K.2
-
4
-
-
0036305380
-
Patients' subjective experiences of antipsychotics. Clinical relevance
-
HELLEWELL J. Patients' subjective experiences of antipsychotics. Clinical relevance. CNS Drugs 2002;16:457-471.
-
(2002)
CNS Drugs
, vol.16
, pp. 457-471
-
-
Hellewell, J.1
-
5
-
-
0032601816
-
Subjective experience and mental side-effects of antipsychotic treatment
-
GERLACH J, LARSEN EB. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatr Scand 1999;99(Suppl. 395):113-117.
-
(1999)
Acta Psychiatr Scand
, vol.99
, Issue.SUPPL. 395
, pp. 113-117
-
-
Gerlach, J.1
Larsen, E.B.2
-
6
-
-
0035015475
-
Subject and observer-rated quality of life in schizophrenia
-
FITZGERALD PB, WILLIAMS CL, CORTELING N, FILIA SL, BREWER K, ADAMS A, DE CASTELLA RA, ROLFE T, DAVEY P, KULKARNI J. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001;103:387-392.
-
(2001)
Acta Psychiatr Scand
, vol.103
, pp. 387-392
-
-
Fitzgerald, P.B.1
Williams, C.L.2
Corteling, N.3
Filia, S.L.4
Brewer, K.5
Adams, A.6
De Castella, R.A.7
Rolfe, T.8
Davey, P.9
Kulkarni, J.10
-
7
-
-
0035032145
-
Influence of novel and conventional antipsychotic medication on subjective quality of life
-
TEMPIER R, PAWLIUK N. Influence of novel and conventional antipsychotic medication on subjective quality of life. J Psychiatr Neurosci 2001;26:131-136.
-
(2001)
J Psychiatr Neurosci
, vol.26
, pp. 131-136
-
-
Tempier, R.1
Pawliuk, N.2
-
8
-
-
0035987326
-
Subjective well-being and quality of life under atypical antipsychotic treatment
-
KAROW A, NABER D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology 2002;162:3-10.
-
(2002)
Psychopharmacology
, vol.162
, pp. 3-10
-
-
Karow, A.1
Naber, D.2
-
9
-
-
0034674458
-
Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life
-
VORUGANTI L, CORTESE L, OYEWUMI L, CERNOVSKY T, ZIRUL S, AWAD A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 2000;43:135-145.
-
(2000)
Schizophr Res
, vol.43
, pp. 135-145
-
-
Voruganti, L.1
Cortese, L.2
Oyewumi, L.3
Cernovsky, T.4
Zirul, S.5
Awad, A.6
-
10
-
-
0036641765
-
Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
-
VORUGANTI LN, AWAD AG. Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 2002;56:37-46.
-
(2002)
Schizophr Res
, vol.56
, pp. 37-46
-
-
Voruganti, L.N.1
Awad, A.G.2
-
11
-
-
2442688064
-
Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice. A naturalistic comparative study
-
RITSNER M, PERELROYZEN G, ILAN H, GIBEL A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice. A naturalistic comparative study. J Clin Psychopharmacol 2004;3:245-253.
-
(2004)
J Clin Psychopharmacol
, vol.3
, pp. 245-253
-
-
Ritsner, M.1
Perelroyzen, G.2
Ilan, H.3
Gibel, A.4
-
12
-
-
14344264873
-
-
Bremen, Germany. UNI-MED Publisher
-
NABER D, LAMBERT M, KRAUSZ M, HAASEN C, PICKAR D. Atypical neuroleptics in the treatment of schizophrenic patients, 2nd edn with special consideration of atypical antipsychotics in child and adolescent psychiatry. Bremen, Germany. UNI-MED Publisher, 2001.
-
(2001)
Atypical Neuroleptics in the Treatment of Schizophrenic Patients, 2nd Edn with Special Consideration of Atypical Antipsychotics in Child and Adolescent Psychiatry
-
-
Naber, D.1
Lambert, M.2
Krausz, M.3
Haasen, C.4
Pickar, D.5
-
14
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
-
KANE JM, HONIGFELD G, SINGER J, MELTZER H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796.
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.M.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
15
-
-
0033558072
-
Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
-
BREIER A, HAMILTON SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol Psychiatry 1999;45:403-411.
-
(1999)
Biol Psychiatry
, vol.45
, pp. 403-411
-
-
Breier, A.1
Hamilton, S.H.2
-
16
-
-
0002141623
-
Refractory schizophrenia
-
Lader M, Naber D, eds . London: Martin Dunitz Publishers
-
NABER D, KRAUSZ M, LAMBERT M, BENDER S. Refractory schizophrenia. In: LADER M, NABER D, eds. Difficult clinical problems in psychiatry. London: Martin Dunitz Publishers, 1999:3-22.
-
(1999)
Difficult Clinical Problems in Psychiatry
, pp. 3-22
-
-
Naber, D.1
Krausz, M.2
Lambert, M.3
Bender, S.4
-
17
-
-
0033008580
-
Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials
-
WAHLBECK K, CHEINE M, ESSALI A, ADAMS C. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999;156:990-999.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 990-999
-
-
Wahlbeck, K.1
Cheine, M.2
Essali, A.3
Adams, C.4
-
18
-
-
0035060791
-
Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine
-
TOLLEFSON GD, BIRKETT MA, KIESLER GM, WOOD AJ and the Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine. Biol Psychiatry 2001;49:52-63.
-
(2001)
Biol Psychiatry
, vol.49
, pp. 52-63
-
-
Tollefson, G.D.1
Birkett, M.A.2
Kiesler, G.M.3
Wood, A.J.4
-
19
-
-
0036159250
-
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
-
VOLAVKA J, CZOBOR P, SHEITMAN B et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 2002;159:255-262.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 255-262
-
-
Volavka, J.1
Czobor, P.2
Sheitman, B.3
-
20
-
-
0031748732
-
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia
-
CONLEY RR, TAMMINGA CA, BARTKO JJ et al. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry 1998;155:914-920.
-
(1998)
Am J Psychiatry
, vol.155
, pp. 914-920
-
-
Conley, R.R.1
Tamminga, C.A.2
Bartko, J.J.3
-
21
-
-
0032986659
-
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
-
CONLEY RR, TAMMINGA CA, KELLY DL, RICHARDSON CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 1999;46:7377.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 7377
-
-
Conley, R.R.1
Tamminga, C.A.2
Kelly, D.L.3
Richardson, C.M.4
-
22
-
-
0041659128
-
Conventional antipsychotic drugs for treatment-resistant schizophrenia: A re-examination
-
MONCRIEFF J, CLOZAPINE V. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. Br J Psychiatry 2003;183:161-166.
-
(2003)
Br J Psychiatry
, vol.183
, pp. 161-166
-
-
Moncrieff, J.1
Clozapine, V.2
-
23
-
-
0024989576
-
Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
-
MELTZER HY, BURNETT S, BASTANI B, RAMIREZ L. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Comm Psychiatry 1990;41:892-897.
-
(1990)
Hosp Comm Psychiatry
, vol.41
, pp. 892-897
-
-
Meltzer, H.Y.1
Burnett, S.2
Bastani, B.3
Ramirez, L.4
-
24
-
-
1542641522
-
Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial
-
REVICKI DA, GENDUSO LA, HAMILTON SH, GANOCZY D, BEASLEY CM Jr. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res 1999;8:417-426.
-
(1999)
Qual Life Res
, vol.8
, pp. 417-426
-
-
Revicki, D.A.1
Genduso, L.A.2
Hamilton, S.H.3
Ganoczy, D.4
Beasley Jr., C.M.5
-
25
-
-
0031905314
-
Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double blind trial
-
HAMILTON S, REVICKI D, GENDUSO L, BEASLE C. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double blind trial. Neuropsychopharmacology 1998;18:41-49.
-
(1998)
Neuropsychopharmacology
, vol.18
, pp. 41-49
-
-
Hamilton, S.1
Revicki, D.2
Genduso, L.3
Beasle, C.4
-
26
-
-
0035972707
-
Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs
-
NABER D, MORITZ S, LAMBERT M et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001;50:79-88.
-
(2001)
Schizophr Res
, vol.50
, pp. 79-88
-
-
Naber, D.1
Moritz, S.2
Lambert, M.3
-
27
-
-
0035987323
-
Psychometric properties of the Subjective Well-Being under Neuroleptics scale and the Subjective Deficit Syndrome Scale
-
DE HAAN L, WEISFELT M, DINGEMANS PM, LINSZEN DH, WOUTERS L. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology (Berl) 2002;162:24-28.
-
(2002)
Psychopharmacology (Berl)
, vol.162
, pp. 24-28
-
-
De Haan, L.1
Weisfelt, M.2
Dingemans, P.M.3
Linszen, D.H.4
Wouters, L.5
-
28
-
-
0344874179
-
Clinical correlates of early medication adherence: West London first episode schizophrenia study
-
MUTSATSA SH, JOYCE EM, HUTTON SB, WEBB E, GIBBINS H, PAUL S, BARNES TRE. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand 2003;108:439-446.
-
(2003)
Acta Psychiatr Scand
, vol.108
, pp. 439-446
-
-
Mutsatsa, S.H.1
Joyce, E.M.2
Hutton, S.B.3
Webb, E.4
Gibbins, H.5
Paul, S.6
Barnes, T.R.E.7
-
29
-
-
0023606101
-
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
-
KAY SR, FISZBEIN A, OPLER LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261-276.
-
(1987)
Schizophrenia Bull
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
30
-
-
0001957397
-
Psychometric testing of the "Münchner Lebensqualitäts Dimensionen Liste (MLDL)
-
Bullinger M, Ludwig M, Steinbüchel V, eds . Göttingen, Toronto, Zürich: Hogrefe Verlag für Psychologie
-
HEINISCH M, LUDWIG M, BULLINGER M. Psychometric testing of the "Münchner Lebensqualitäts Dimensionen Liste (MLDL). In: BULLINGER M, LUDWIG M, STEINBüCHEL V, eds. Lebensqualität bei kardiovaskulären Erkrankungen. Göttingen, Toronto, Zürich: Hogrefe Verlag für Psychologie, 1991.
-
(1991)
Lebensqualität Bei Kardiovaskulären Erkrankungen
-
-
Heinisch, M.1
Ludwig, M.2
Bullinger, M.3
-
32
-
-
0003412410
-
-
Rockville, MD: National Institute of Mental Health, Dhew Publication No. (Adm)
-
GUY W. Assessment manual for psychopharmacology, revised. Rockville, MD: National Institute of Mental Health, Dhew Publication No. (Adm), 1976:76-338.
-
(1976)
Assessment Manual for Psychopharmacology, Revised
, pp. 76-338
-
-
Guy, W.1
-
34
-
-
0032529072
-
Therapeutic equivalence investigations: Statistical considerations
-
RÖHMEL J. Therapeutic equivalence investigations: statistical considerations. Stat Med 1998;17:1703-1714.
-
(1998)
Stat Med
, vol.17
, pp. 1703-1714
-
-
Röhmel, J.1
-
35
-
-
14344253616
-
Rapid improvement of subjective well-being after successful switch of psychotic outpatients to Olanzapine: Results from an open-label phase III study
-
in press
-
KLUGE M, KESSLER F, LANGER F et al. Rapid improvement of subjective well-being after successful switch of psychotic outpatients to Olanzapine: results from an open-label phase III study. Pharmacopsychiatry 2005 (in press).
-
(2005)
Pharmacopsychiatry
-
-
Kluge, M.1
Kessler, F.2
Langer, F.3
-
36
-
-
14344256502
-
Association of clinical and non-clinical factors with subjective well-being: Data of the SOHO study
-
KAROW A, RITZHAUPT A, ROESCH F, NOVICK D, NABER D, DITTMANN RW. Association of clinical and non-clinical factors with subjective well-being: data of the SOHO study. Pharmacopsychiatry 2003;36:239.
-
(2003)
Pharmacopsychiatry
, vol.36
, pp. 239
-
-
Karow, A.1
Ritzhaupt, A.2
Roesch, F.3
Novick, D.4
Naber, D.5
Dittmann, R.W.6
-
37
-
-
0030756517
-
Comparison of clozapine and haloperidol in hospitalised patients with refractory schizophrenia
-
Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
-
ROSENHECK R, CRAMER J, XU W et al. Comparison of clozapine and haloperidol in hospitalised patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med 1997;337:809-815.
-
(1997)
N Engl J Med
, vol.337
, pp. 809-815
-
-
Rosenheck, R.1
Cramer, J.2
Xu, W.3
-
38
-
-
10744231049
-
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
-
BITTER I, DOSSENBACH MR, BROOK S et al. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry 2004;28:173-180.
-
(2004)
Progr Neuro-Psychopharmacol Biol Psychiatry
, vol.28
, pp. 173-180
-
-
Bitter, I.1
Dossenbach, M.R.2
Brook, S.3
-
39
-
-
0028072032
-
Clozapine dose in the United States and Europe: Implications for therapeutic and adverse effects
-
FLEISCHHACKER W, HUMMER M, KURZ M et al. Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects. J Clin Psychiatry 1994;55(Suppl. 9):78-81.
-
(1994)
J Clin Psychiatry
, vol.55
, Issue.SUPPL. 9
, pp. 78-81
-
-
Fleischhacker, W.1
Hummer, M.2
Kurz, M.3
-
40
-
-
0024998253
-
The European experience with the use of clozapine
-
NABER D, HIPPIUS H. The European experience with the use of clozapine. Hosp Com Psychiatry 1990;41:886-890.
-
(1990)
Hosp Com Psychiatry
, vol.41
, pp. 886-890
-
-
Naber, D.1
Hippius, H.2
-
41
-
-
0037227192
-
Clozapine treatment for suicidality in schizophrenia
-
MELTZER HY, ALPHS L, GREEN AI et al, for the InterSePT Study Group. Clozapine treatment for suicidality in schizophrenia. Arch Gen Psychiatry 2003;60:82-91.
-
(2003)
Arch Gen Psychiatry
, vol.60
, pp. 82-91
-
-
Meltzer, H.Y.1
Alphs, L.2
Green, A.I.3
-
42
-
-
0030097546
-
Dose related response to clozapine in a state psychiatric hospital population: A naturalistic study
-
GORDON BJ, MILKE DJ. Dose related response to clozapine in a state psychiatric hospital population: a naturalistic study. Psychiatr Q 1996;67:65-74.
-
(1996)
Psychiatr Q
, vol.67
, pp. 65-74
-
-
Gordon, B.J.1
Milke, D.J.2
-
43
-
-
0028810763
-
A comparison of European and American dosing regimens of schizophrenic patients on clozapine: Efficacy and side effects
-
POLLACK S, LIEBERMAN JA, FLEISCHHACKER WW et al. A comparison of European and American dosing regimens of schizophrenic patients on clozapine: efficacy and side effects. Psychopharmacol Bull 1995;31:315-320.
-
(1995)
Psychopharmacol Bull
, vol.31
, pp. 315-320
-
-
Pollack, S.1
Lieberman, J.A.2
Fleischhacker, W.W.3
-
44
-
-
0032751075
-
Antipsychotic-induced weight gain: A comprehensive research synthesis
-
ALLISON DB, MENTORE JL, HEO M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1686-1696
-
-
Allison, D.B.1
Mentore, J.L.2
Heo, M.3
|